IS5141A - Atrópínísómerur af 3-heteróarýl-4(3H)-kínazólínónum til meðhöndlunar á ástandi sem tengist taugahrörnun og áverkum á miðtaugakerfi - Google Patents
Atrópínísómerur af 3-heteróarýl-4(3H)-kínazólínónum til meðhöndlunar á ástandi sem tengist taugahrörnun og áverkum á miðtaugakerfiInfo
- Publication number
- IS5141A IS5141A IS5141A IS5141A IS5141A IS 5141 A IS5141 A IS 5141A IS 5141 A IS5141 A IS 5141A IS 5141 A IS5141 A IS 5141A IS 5141 A IS5141 A IS 5141A
- Authority
- IS
- Iceland
- Prior art keywords
- quinazolinones
- atropine
- neurodegenerative
- heteroaryl
- isomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3854097P | 1997-02-28 | 1997-02-28 | |
| PCT/IB1998/000151 WO1998038187A1 (en) | 1997-02-28 | 1998-02-06 | Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5141A true IS5141A (is) | 1999-07-30 |
Family
ID=21900535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5141A IS5141A (is) | 1997-02-28 | 1999-07-30 | Atrópínísómerur af 3-heteróarýl-4(3H)-kínazólínónum til meðhöndlunar á ástandi sem tengist taugahrörnun og áverkum á miðtaugakerfi |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US6380204B1 (is) |
| EP (1) | EP0964860B1 (is) |
| JP (1) | JP3299990B2 (is) |
| KR (1) | KR20000075812A (is) |
| CN (1) | CN1248254A (is) |
| AP (1) | AP9801202A0 (is) |
| AR (1) | AR011886A1 (is) |
| AT (1) | ATE264854T1 (is) |
| AU (1) | AU732448B2 (is) |
| BG (1) | BG103687A (is) |
| BR (1) | BR9807807A (is) |
| CA (1) | CA2282279C (is) |
| CO (1) | CO4950615A1 (is) |
| DE (1) | DE69823339T2 (is) |
| DK (1) | DK0964860T3 (is) |
| DZ (1) | DZ2438A1 (is) |
| EA (1) | EA001961B1 (is) |
| ES (1) | ES2218801T3 (is) |
| GT (1) | GT199800039A (is) |
| HN (1) | HN1998000028A (is) |
| HR (1) | HRP980108B1 (is) |
| HU (1) | HUP0000935A3 (is) |
| ID (1) | ID23435A (is) |
| IL (1) | IL130897A0 (is) |
| IS (1) | IS5141A (is) |
| MA (1) | MA24485A1 (is) |
| NO (1) | NO994178D0 (is) |
| NZ (1) | NZ336627A (is) |
| OA (1) | OA11088A (is) |
| PA (1) | PA8446901A1 (is) |
| PE (1) | PE57999A1 (is) |
| PL (1) | PL335307A1 (is) |
| PT (1) | PT964860E (is) |
| SK (1) | SK113199A3 (is) |
| TN (1) | TNSN98034A1 (is) |
| TR (1) | TR199902094T2 (is) |
| TW (1) | TW530055B (is) |
| UA (1) | UA58536C2 (is) |
| WO (1) | WO1998038187A1 (is) |
| ZA (1) | ZA981665B (is) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6323208B1 (en) | 1997-09-05 | 2001-11-27 | Pfizer Inc | Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones |
| JPH11279158A (ja) * | 1998-02-09 | 1999-10-12 | Pfizer Prod Inc | キナゾリン―４―オン誘導体の製造方法 |
| US6890930B1 (en) * | 1999-09-28 | 2005-05-10 | 3-Dimensional Pharmaceuticals, Inc. | Quinazolinones |
| US20080146562A1 (en) * | 2003-08-08 | 2008-06-19 | Ulysses Pharmaceutical Products Inc., | Halogenated quinazolinyl nitrofurans as antibacterial agents |
| US7410974B2 (en) * | 2003-08-08 | 2008-08-12 | Ulysses Pharmaceutical Products, Inc. | Halogenated Quinazolinyl nitrofurans as antibacterial agents |
| GB0416730D0 (en) | 2004-07-27 | 2004-09-01 | Novartis Ag | Organic compounds |
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| CN101355946B (zh) * | 2005-11-04 | 2013-05-08 | 海德拉生物科学公司 | 调节trpv3功能的化合物 |
| KR101129868B1 (ko) * | 2006-10-04 | 2012-04-12 | 화이자 프로덕츠 인코포레이티드 | 칼슘 수용체 길항제로서의 피리도［4,3-ｄ］피리미딘-4(3Ｈ)-온 유도체 |
| WO2008140750A1 (en) * | 2007-05-10 | 2008-11-20 | Hydra Biosciences Inc. | Compounds for modulating trpv3 function |
| WO2010111432A1 (en) * | 2009-03-24 | 2010-09-30 | Calistoga Pharmaceuticals Inc. | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| US8846000B2 (en) | 2009-05-29 | 2014-09-30 | Merck Sharp & Dohme Corp. | Radiolabeled PDE10 inhibitors |
| WO2013105985A1 (en) * | 2011-02-28 | 2013-07-18 | Philadelphia Health & Education Corporation | Small molecule inhibitors of rad51 recombinase and methods thereof |
| CN115335050B (zh) | 2020-01-29 | 2024-05-17 | 卡玛瑞制药有限公司 | 用于治疗皮肤病症的化合物和组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3748325A (en) * | 1970-04-06 | 1973-07-24 | Karamchand Premchand Private | Process for the preparation of quinazolinone derivatives |
| US4183931A (en) | 1977-09-08 | 1980-01-15 | Research Corporation | 2-Ketoalkyl-4(3H)-quinazolinones |
| WO1992013535A1 (en) * | 1991-02-06 | 1992-08-20 | Research Corporation Technologies, Inc. | Anticonvulsant substituted quinazolones |
| DE69716810T2 (de) * | 1996-05-15 | 2003-02-27 | Pfizer Inc., New York | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one |
| EA002905B1 (ru) * | 1996-05-15 | 2002-10-31 | Пфайзер Инк. | 2,3-двузамещенные-4(3н)-хиназолиноны и содержащая их фармацевтическая композиция |
-
1998
- 1998-02-06 PT PT98901424T patent/PT964860E/pt unknown
- 1998-02-06 EA EA199900689A patent/EA001961B1/ru not_active IP Right Cessation
- 1998-02-06 JP JP53744998A patent/JP3299990B2/ja not_active Expired - Fee Related
- 1998-02-06 PL PL98335307A patent/PL335307A1/xx unknown
- 1998-02-06 ID IDW990935D patent/ID23435A/id unknown
- 1998-02-06 NZ NZ336627A patent/NZ336627A/xx unknown
- 1998-02-06 BR BR9807807-0A patent/BR9807807A/pt not_active Application Discontinuation
- 1998-02-06 DK DK98901424T patent/DK0964860T3/da active
- 1998-02-06 TR TR1999/02094T patent/TR199902094T2/xx unknown
- 1998-02-06 WO PCT/IB1998/000151 patent/WO1998038187A1/en not_active Ceased
- 1998-02-06 US US09/380,114 patent/US6380204B1/en not_active Expired - Fee Related
- 1998-02-06 KR KR1019997007885A patent/KR20000075812A/ko not_active Abandoned
- 1998-02-06 AT AT98901424T patent/ATE264854T1/de not_active IP Right Cessation
- 1998-02-06 CN CN98802796A patent/CN1248254A/zh active Pending
- 1998-02-06 ES ES98901424T patent/ES2218801T3/es not_active Expired - Lifetime
- 1998-02-06 AU AU57759/98A patent/AU732448B2/en not_active Ceased
- 1998-02-06 SK SK1131-99A patent/SK113199A3/sk unknown
- 1998-02-06 DE DE69823339T patent/DE69823339T2/de not_active Expired - Fee Related
- 1998-02-06 EP EP98901424A patent/EP0964860B1/en not_active Expired - Lifetime
- 1998-02-06 HU HU0000935A patent/HUP0000935A3/hu unknown
- 1998-02-06 IL IL13089798A patent/IL130897A0/xx unknown
- 1998-02-06 CA CA002282279A patent/CA2282279C/en not_active Expired - Fee Related
- 1998-02-09 HN HN1998000028A patent/HN1998000028A/es unknown
- 1998-02-17 PA PA19988446901A patent/PA8446901A1/es unknown
- 1998-02-19 GT GT199800039A patent/GT199800039A/es unknown
- 1998-02-23 PE PE1998000127A patent/PE57999A1/es not_active Application Discontinuation
- 1998-02-25 MA MA24979A patent/MA24485A1/fr unknown
- 1998-02-25 CO CO98010303A patent/CO4950615A1/es unknown
- 1998-02-25 TW TW087102713A patent/TW530055B/zh not_active IP Right Cessation
- 1998-02-25 TN TNTNSN98034A patent/TNSN98034A1/fr unknown
- 1998-02-25 DZ DZ980048A patent/DZ2438A1/xx active
- 1998-02-26 AP APAP/P/1998/001202A patent/AP9801202A0/en unknown
- 1998-02-26 AR ARP980100872A patent/AR011886A1/es unknown
- 1998-02-27 ZA ZA9801665A patent/ZA981665B/xx unknown
- 1998-02-27 HR HR980108A patent/HRP980108B1/xx not_active IP Right Cessation
- 1998-06-02 UA UA99084850A patent/UA58536C2/uk unknown
-
1999
- 1999-07-30 IS IS5141A patent/IS5141A/is unknown
- 1999-08-20 OA OA9900186A patent/OA11088A/fr unknown
- 1999-08-24 BG BG103687A patent/BG103687A/xx unknown
- 1999-08-27 NO NO994178A patent/NO994178D0/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5141A (is) | Atrópínísómerur af 3-heteróarýl-4(3H)-kínazólínónum til meðhöndlunar á ástandi sem tengist taugahrörnun og áverkum á miðtaugakerfi | |
| DK0830864T3 (da) | Kombinationsbehandling til behandling af psykoser | |
| DK0694531T3 (da) | Fremgangsmåde til fremstilling af vandfortyndbare urethanharpikser og deres anvendelse | |
| DK0751129T6 (da) | Substituerede dihydrodibenzo(b,f)azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle lidelser i centralnervesystemet og farmaceutiske sammensætninger indeholdende disse | |
| DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
| DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
| DK1083889T3 (da) | Tetrahydronaphthalenforbindelser og deres anvendelse til behandling af neurodegenerative sygdomme | |
| NO996483L (no) | Imidasopyrimidiner og imidasopyridiner for behandling av neurologiske lidelser | |
| DK1339406T3 (da) | Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet | |
| DK0969845T3 (da) | Nye terapeutiske kombinationer af mirtazapin og antipsykotika til behandling eller forebyggelse af psykotiske sygdomme | |
| NO20014674D0 (no) | Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser | |
| DK0908458T3 (da) | Substituerede pyridylmethylpiperazin- og piperidinderivater, deres fremstilling samt deres anvendelse til behandling af lidelser i centralnervesystemet (CNS) | |
| DK0917464T3 (da) | Anvendelse af aminer til fremstilling af lægemidler til forebyggelse af tumorcelleproliferation | |
| DK1041985T3 (da) | Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme | |
| EE200000391A (et) | Triasiiniühendid kesknärvisüsteemihäirete raviks | |
| NO20012106L (no) | Middel for behandling av forstyrrelser i benmetabolismen | |
| DK0819113T3 (da) | Benzamider til behandling af neurodegenerative forstyrrelser | |
| IL152688A0 (en) | Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system | |
| DK1121356T3 (da) | 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser | |
| DK0981349T3 (da) | 5-alfa-pregnan-3-beta-ol-20-on-sulfat til behandling af tumorer og CNS sygdomme | |
| IS6098A (is) | Ósantant til meðhöndlunar á skaptruflunum | |
| DK1011678T3 (da) | Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser | |
| FI953747A0 (fi) | Steroideja vaihdevuosivaivojen hoitoon | |
| IS6619A (is) | S-metýl-díhýdró-siprasídón til meðhöndlunar á geðrænum kvillum og augnkvillum | |
| DK0964681T3 (da) | Antikonvulsive derivater til behandling af psoriasis |